BAXTER INTERNATIONAL INC acquired ApaTech Limited for $337M, a transaction completed in March 2010, structured as Acquisition of all outstanding equity; $247 million up-front plus up to $90 million in milestone-based contingent payments.
ApaTech Limited operates in BioScience, is based in United Kingdom. Baxter acquired ApaTech, a U.K.-based orthobiologic products company, gaining ACTIFUSE, a silicate-substituted calcium phosphate synthetic bone-graft material marketed in the United States, Europe and other markets, along with manufacturing and R&D facilities in the U.K., the United States and Germany. The acquisition complemented Baxter's regenerative-medicine capabilities.
Added the ACTIFUSE synthetic bone-graft platform and expanded Baxter's regenerative-medicine and biosurgery capabilities.
Advisory firms were not disclosed for this transaction.